Concourse Financial Group Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15
| Closed | -$930 | – | 993 |
|
|
2024
Q4 | $930 | Hold |
15
| – | – | ﹤0.01% | 2106 |
|
|
2024
Q3 | $1.05K | Sell |
15
-36
| -71% | -$2.53K | ﹤0.01% | 2060 |
|
|
2024
Q2 | $4.2K | Sell |
51
-4,437
| -99% | -$365K | ﹤0.01% | 1898 |
|
|
2024
Q1 | $392K | Buy |
4,488
+251
| +6% | +$21.9K | 0.03% | 492 |
|
|
2023
Q4 | $409K | Sell |
4,237
-235
| -5% | -$22.7K | 0.03% | 485 |
|
|
2023
Q3 | $396K | Buy |
4,472
+292
| +7% | +$25.8K | 0.03% | 457 |
|
|
2023
Q2 | $362K | Buy |
4,180
+454
| +12% | +$39.4K | 0.03% | 493 |
|
|
2023
Q1 | $362K | Buy |
3,726
+1,112
| +43% | +$108K | 0.03% | 496 |
|
|
2022
Q4 | $271K | Sell |
2,614
-400
| -13% | -$41.4K | 0.02% | 542 |
|
|
2022
Q3 | $255K | Sell |
3,014
-141
| -4% | -$11.9K | 0.02% | 488 |
|
|
2022
Q2 | $261K | Sell |
3,155
-1,966
| -38% | -$163K | 0.02% | 537 |
|
|
2022
Q1 | $395K | Sell |
5,121
-5,274
| -51% | -$407K | 0.03% | 475 |
|
|
2021
Q4 | $918K | Buy |
10,395
+308
| +3% | +$27.2K | 0.05% | 347 |
|
|
2021
Q3 | $780K | Buy |
10,087
+1,286
| +15% | +$99.4K | 0.05% | 376 |
|
|
2021
Q2 | $734K | Buy |
8,801
+1,512
| +21% | +$126K | 0.05% | 372 |
|
|
2021
Q1 | $550K | Buy |
7,289
+4,787
| +191% | +$361K | 0.04% | 408 |
|
|
2020
Q4 | $219K | Buy |
2,502
+1,408
| +129% | +$123K | 0.02% | 603 |
|
|
2020
Q3 | $83K | Buy |
1,094
+987
| +922% | +$74.9K | 0.01% | 850 |
|
|
2020
Q2 | $13K | Buy |
107
+20
| +23% | +$2.43K | ﹤0.01% | 1415 |
|
|
2020
Q1 | $7K | Buy |
87
+9
| +12% | +$724 | ﹤0.01% | 1539 |
|
|
2019
Q4 | $7K | Buy |
78
+49
| +169% | +$4.4K | ﹤0.01% | 1521 |
|
|
2019
Q3 | $2K | Sell |
29
-537
| -95% | -$37K | ﹤0.01% | 1509 |
|
|
2019
Q2 | $48K | Buy |
566
+387
| +216% | +$32.8K | ﹤0.01% | 876 |
|
|
2019
Q1 | $15K | Buy |
179
+69
| +63% | +$5.78K | ﹤0.01% | 1358 |
|
|
2018
Q4 | $9K | Sell |
110
-51
| -32% | -$4.17K | ﹤0.01% | 1445 |
|
|
2018
Q3 | $16K | Buy |
+161
| New | +$16K | ﹤0.01% | 926 |
|